Having trouble accessing articles? Reset your cache.

Management tracks: Galderma taps new leadership from Shire; plus iOmx, BioSpecifics, Poseida, Kedalion, GenSight, Lyra, Verrica and Mizuho

Former Shire CEO Flemming Ørnskov will lead newly independent Galderma Laboratories L.P. as CEO. Joining him is fellow Shire vet Thomas Dittrich, who will be CFO, the same post he held at Shire. The pair led Shire through its $62 billion acquisition by Takeda Pharmaceutical

Read the full word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers